Results 131 to 140 of about 54,330 (287)
Nanomedicine for the Treatment of Non-Hodgkin Lymphoma [PDF]
, 2019 Non-Hodgkin lymphoma, or NHL, is the predominant category of lymphoma. NHL is a type of lymphoid hematopoietic malignancy which approximately 70,000 Americans are diagnosed with annually, with the number of diagnoses growing annually.
Gandhi, B.Pharm, Tanvi
core +1 more source
Family history of haematological malignancy and prognosis across non‐Hodgkin lymphoma subtypes
British Journal of Haematology, Volume 208, Issue 5, Page 1631-1640, May 2026.Multivariable‐adjusted associations between family history of haematological malignancy (FHHM) and survival outcomes by non‐Hodgkin lymphoma subtype [OS (A), EFS (B), LSS (C) and failure to achieve EFS at 24 months (D)]. Subtype‐specific analyses showed that FHHM was associated with significantly inferior EFS in MCL and inferior LSS in FL.
George A. Cholack +16 more
wiley +1 more source
A Defect of the INK4-Cdk4 Checkpoint and Myc Collaborate in Blastoid Mantle Cell Lymphoma–Like Lymphoma Formation in Mice [PDF]
, 2012 Christelle Vincent‐Fabert +9 more
openalex +1 more source
British Journal of Pharmacology, Volume 183, Issue 10, Page 2446-2463, May 2026.Background and Purpose Bruton tyrosine kinase (Btk) is essential for B cell function. Its role in myeloid cells is less understood. Greater insights into Btk significance in myeloid cells are needed to evaluate its potential as a therapeutic target during the effector phase of antibody‐induced autoimmune diseases, where inhibiting autoantibody ...
Henning Olbrich +7 more
wiley +1 more source
Integrating Flow Cytometry in the Diagnostic Work of HIV‐Associated Hodgkin's Lymphomas
Journal of Cellular and Molecular Medicine, Volume 30, Issue 9, May 2026.ABSTRACT Hodgkin lymphoma (HL) is prevalent worldwide and typically presents symptoms like sudden pain, swelling, and weight loss. Classical HL (cHL) is largely treatable with modern risk‐adapted and response‐based therapy. cHL represents one of the most common malignancies occurring during the course of evolution in patients living with HIV.
Maria Santa +23 more
wiley +1 more source
A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma [PDF]
, 2020 Hun Ju Lee +5 more
openalex +1 more source
Clinical and biological features of mantle cell lymphoma patients with co-expression of CD10 and BCL-6: a retrospective study [PDF]
, 2021 Wanzi Chen +3 more
openalex +1 more source